Artiva Biotherapeutics ARTV
NASDAQ ARTV
$4.07 +0.01 (+0.25%)
At close: Nov 11, 2026 · 4:00 PM EST

Artiva Biotherapeutics (ARTV) Long-Term Investments (2024)

Updated

Artiva Biotherapeutics (ARTV) recorded Long-Term Investments of $52.97 million in Q3 2024.

Analysis

Artiva Biotherapeutics (ARTV) Long-Term Investments (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.01 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 387.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.60 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 63.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 268.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.45 Bn
10 Artiva Biotherapeutics 200.70 Mn -118.40 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 52.97 Mn
API Access

Artiva Biotherapeutics Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=ARTV&period=max&api_key=YOUR_API_KEY